Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 2, 2012, Pages 182-188

  Sokup, Alina ^a,b   Góralczyk, Barbara ^a   Góralczyk, Krzysztof ^a   Rość, Danuta ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Dr J Biziel University Hospital   (Poland)

Author keywords

cardiovascular risk; E selectin; Gestational diabetes; impaired glucose tolerance; triglycerides

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BODY FAT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL; DIABETES, GESTATIONAL; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE METABOLISM DISORDERS; HUMANS; INSULIN; INTERCELLULAR ADHESION MOLECULE-1; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR DISEASES; VON WILLEBRAND FACTOR;

EID: 84856088501     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01289.x     Document Type: Article

References (23)

1. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
2. Shah BR, Retnakaran R, Booth GL,. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008; 31: 1668-9.
3. Kannel WB, Vason RS,. Triglycerides as vascular risk factors: new epidemiological insights. Curr Opin Cardiol. 2009; 24: 345-50.
4. Mykkänen I, Kuisisto J, Pyörälä K, Laakso M,. Cardiovascular disease risk factors as predictors of type 2 (non-insulin- dependent) diabetes mellitus in elderly subjects. Diabetologia. 1993; 36: 553-9. (Pubitemid 23161224)
5. Tirosh A, Shah I, Pritzur R, Kochbe I, Tekes-Manova D, Israeli E, et al,. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care. 2008; 31: 2032-7.
6. Dotevall A, Johansson S, Wilhansen L, Rosengren A,. Increased level of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA Study. Diabet Med. 2004; 21: 615-22. (Pubitemid 38746284)
7. McPhillips JB, Berret-Connor E, Wingard DC,. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol. 1990; 131: 443-53. (Pubitemid 20051740)
8. Morimitsu LK, Fusaro AS, Sanchez VH, Hageman CC, Bertini AM,. Fibrynolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes. Diabetes Res Clin Pract. 2007; 78: 340-8. (Pubitemid 350030317)
9. Riveiro K, Portal VL, Vieira M, Behle I, Bartha JC, Marin-Segura P, et al,. Ultrsound evaluation of visceral fat and metabolic risk factors during early pregnancy. Obesity. 2007; 15: 2233-9. (Pubitemid 350004091)
10. Tarim E, Yigit F, Kilicda GE, Bagis F, Damircan S, Sinsek E, et al,. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol. 2006; 27: 177-82. (Pubitemid 43733734)
11. Matthews DR, Hosker IP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function for fasting plasma glucose and insulin concentration in man. Diabetologia. 1985; 28: 412-5.
12. Heitreiter SM, Solomon CG, Mitchell GF, Skali-Clunis N, Seely EW,. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 2005; 90: 3983-8. (Pubitemid 41058161)
13. Volpe L, Cuccuru I, Lencioni C, Napoli V, Chio A, Fotino C, et al,. Early subclinical atherosclerosis in women with previous gestational diabetes mellitus. Diabetes Care. 2008; 31: e32.
14. Pallardo F, Herranz L, Garcia-Ingelmo T, Grande C, Martin-Vaquero P, Jañez M, et al,. Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care. 1999; 22: 1053-8. (Pubitemid 29293954)
15. Kim C, Cheng YJ, Beckles GL,. Cardiovascular disease risk profiles in women with histories of gestational diabetes but without current diabetes. Obstet Gynecol. 2008; 112: 875-83.
16. Meigs JB, Williams K, Sullivan LM, Hurt KJ, Haffner SM, Stern P, et al,. Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care. 2004; 27: 1417-26. (Pubitemid 38679992)
17. Ferrada C, Molina M, Cid L, Riedel G, Arévado R,. Relationship between gestational diabetes and metabolic syndrome. (Relation entre diabetes gestacional y sindrome metabolico.) Rev Med Chil. 2007; 135: 1539-45.
18. Pallardo LF, Herranz I, Martin-Vaquero P, Garcia-Ingelmo T, Grande C, Jañez M,. Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile. Diabetes Care. 2003; 26: 2318-22. (Pubitemid 36993319)
19. Rizzo M, Berneis K,. Small, dense low-density-lipoproteins and the metabolic syndrome. Diabetes Metab Res Rev. 2007; 23: 14-20. (Pubitemid 46152481)
20. Esteve E, Ricart W, Fernández-Real JM,. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr. 2005; 24: 16-31.
21. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, et al,. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006; 49: 755-65. (Pubitemid 43357551)
22. Ginsberg HN, Ahang YL, Hernandez-Ono A,. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005; 36: 232-40. (Pubitemid 40755136)
23. Boden G, Shulman GI,. Free fatty acids in obesity and type 2 diabetes: defining the role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 2002; 32: 14-23. (Pubitemid 41704996)